| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |